
Sammi Brown
@sammi_brown8
Research biostatistician @mskbiostats | Tweets are my own
ID: 1377029189803577347
30-03-2021 22:45:25
50 Tweet
60 Followers
64 Following

#CycleForSurvival 🚴is a movement dedicated to raising money for rare cancer research at Memorial Sloan Kettering Cancer Center In honor of #WorldCancerDay, please consider supporting our team (Team Bell Curve). All donations made today will be matched! secure2.convio.net/mskcc/site/TR?…

Thank you to Success Academy for hosting our 2nd-ever in-person “Biostats Day” at the Success Academy Harlem High School campus!! We had a great time showcasing the field of Biostatistics to a great group of engaged & inquisitive scholars.


Well well! Want to reduce ICANS during CAR-T for #lymsm? Consult geriatrics for older patients! MOA: Potentially ⬇️ polypharmacy... very cool! Great work in Blood Advances by Gunjan Shah Michael Scordo @sean_m_devlin @DrMiguelPerales Sergio Giralt et al! ashpublications.org/bloodadvances/…


Looking forward to presenting at #RMed2023 with our Memorial Sloan Kettering Biostatistics Service R package dream team 💫Sammi Brown Karissa Whiting Hannah Fuchs💫


📢🔥🚨Our very own #MSKBiostats 💫R package dream team Jessica Lavery Sammi Brown Karissa Whiting Hannah Fuchs will be co-presenting at #RMed2023 ⏰June 7 (Wed) at 11am-12pm ET 📌events.linuxfoundation.org/r-medicine/pro… Memorial Sloan Kettering Cancer Center #CancerResearch #biostatistics R Consortium #DataAnalytics


New #JITC article: Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study jitc.bmj.com/content/11/7/e… @ArielleElkrief João Alessi, MD Xinan Wang Charlie Rudin Mark Awad


Featured today by MSK Library: Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study dx.doi.org/10.1136/jitc-2…

The Simplified Comorbidity Index (SCI) is a novel risk score for allogeneic hematopoietic cell transplantation (HCT) that captures high-yield comorbidities (pulmonary, renal, liver, and cardiac) and age. Roni Shouval buff.ly/3ExlZYE


We identify optimal SRS timing as third week post surgery for resected #brainmets to minimize local failure and radiation effects Memorial Sloan Kettering Biostatistics Service Brain Metastasis Program @ MSK Neurosurgery at Memorial Sloan Kettering Nelson Moss Kathy Panageas Sammi Brown Evan D Bander jamanetwork.com/journals/jaman…



Today I want to highlight the {genieBPC} #rstats package by Jessica Lavery, Sammi Brown, Hannah Fuchs, Axel Martin, Daniel Sjoberg, and myself (Karissa Whiting). It offers functions for pulling and processing data from the AACR GENIE BPC Project genie-bpc.github.io/genieBPC/ #cran


✨First, a quick intro to the AACR GENIE BPC project✨ #GENIEBPC is an effort to aggregate comprehensive clinical data linked to genomic sequencing data to create a public, pan-cancer data repository Jessica Lavery Sammi Brown Hannah Fuchs Kathy Panageas Gʀᴇɢᴏʀʏ Rɪᴇʟʏ #CancerResearch

The result is a rich resource of multi-institutional (Memorial Sloan Kettering Cancer Center Dana-Farber @VUMC_Cancer University Health Network) data on 👤patient characteristics 💊drug regimens 🩻 imaging 🩹#pathology 📈outcomes 🧬#genomics Now available for #NSCLC, #CRC, #breastcancer #prostate #bladder cancer


📢On 4/6 #MSKBiostats Kathy Panageas & Sammi Brown, Bin Zhu from National Cancer Institute & Alex Paynter from AACR will present at #AACR24 workshop “Analytic Resources and Applications for AACR Project GENIE BPC Clinico-genomic Data” ⭐️Joint work w/ Jessica Lavery Hannah Fuchs Karissa Whiting

🚴 #CycleForSurvival is a movement dedicated to raising money for rare cancer research 🚨 All donations are being matched today! Cycle for Survival ❗️ Please consider supporting our team (Team Bell Curve) by donating today! mskcc.convio.net/goto/BellCurve


Thank you all who attended Cycle for Survival🚴♀️on Mar 7th Sammi Brown Mithat Gönen #MSKBiostats This year Team Bell Curve raised a total of $10,151 toward rare cancer research👏Major thanks to everyone who supported us! Donations are open until April 15th: mskcc.convio.net/goto/BellCurve
